FDA Grants Santhera a Development Grant for Muscular Dystrophy Trial
Sufferers of congenital muscular dystrophy (CMD) have been offered a glimmer of hope with the announcement of a development grant for the trial of a promising new drug. Image Credit The US Food and Drug Administration (FDA) has awarded pharmaceutical company Santhera a grant of $246,000 to support its phase one trial of omigapil, which